Study guide
6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection
Certified Burn Registered Nurse CBRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Foundations of Burn Care
1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones
2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response
2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology
3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria
3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics
4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)
4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy
5 Chapter 5: Airway Management & Inhalation Injury Management
5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)
6 Chapter 6: Acute Multisystem Assessment & Critical Care Management
6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection
7 Chapter 7: Hypermetabolism & Nutritional Support
7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation
8 Chapter 8: Pain Management in Burn Care
8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction
9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus
9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients
10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings
10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances
11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure
11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management
12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy
12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion
13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries
13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy
14 Chapter 14: Special Burn Populations & Cutaneous Syndromes
14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries
15 Chapter 15: Rehabilitation, Scar Management & Reconstruction
15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management
16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage
16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response
6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection
Key Takeaways Explain This Topic AI
Neurological alterations in burn injury (burn encephalopathy) arise from cerebral hypoperfusion, systemic inflammatory cytokine storms, severe electrolyte fluctuations, toxic inhalants (carbon monoxide and hydrogen cyanide), and ICU delirium; systematic screening using validated tools (CAM-ICU or ICDSC) is mandatory to guide targeted non-pharmacological and pharmacological bundles.
Peripheral compression neuropathies frequently complicate severe burns due to massive circumferential tissue edema, improper immobilization, or rigid splinting; the common peroneal nerve (at the fibular head) and the ulnar nerve (at the cubital tunnel) are most vulnerable, requiring specialized padding and neutral anti-deformity positioning.
Thermal trauma produces an acute biphasic hematological response: immediate hemoconcentration (hematocrit 50–60%) in the initial 24 hours from plasma volume extravasation, transitioning into profound 'Anemia of Burn Injury' driven by microangiopathic thermal hemolysis, shortened RBC half-life, systemic inflammatory suppression of erythropoiesis (TNF-alpha, IL-6), and massive blood loss during tangential surgical excisions.
A restrictive blood transfusion strategy (transfusion trigger at hemoglobin 7.0–8.0 g/dL) is standard for hemodynamically stable burn critical care patients, significantly reducing transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), immunosuppression, and infectious morbidity compared to liberal transfusion triggers.
Burn-induced coagulopathy presents as early hypercoagulability and microvascular thrombosis that can progress to consumption coagulopathy; patients carry an extreme risk for deep vein thrombosis (DVT) and pulmonary embolism (PE), necessitating protocolized chemical thromboprophylaxis (low-molecular-weight heparin with anti-Xa monitoring) combined with mechanical compression on unburned extremities.
Last updated: August 2026
6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection
Core Knowledge: The systemic reach of major burn trauma extends deeply into the neurological, hematological, and musculoskeletal systems. Clinicians must navigate complex diagnostic challenges—from differentiating burn encephalopathy and toxic inhalants to managing profound burn anemia without over-transfusing blood products. Meticulous positioning, anti-Xa-guided thromboprophylaxis, and early mobilization are vital to prevent lifelong physical disability and fatal thromboembolism.
1. Neurological Derangements & Burn Encephalopathy
Central nervous system (CNS) dysfunction in burn critical care ranges from acute confusion and agitation to profound lethargy, seizures, and coma. Thermal injury does not cause direct brain damage unless accompanied by blast trauma, electrical current passage, or severe hypoxia. SPECTRUM OF NEUROLOGICAL IMPAIRMENT IN BURNS
- ┌────────────────────────────────────────────────────────────────────────────────────────┐
- │ PRIMARY SYSTEMIC DRIVERS │
- ├────────────────────────────────────────────────────────────────────────────────────────┤
- │ [1] TOXIC INHALANTS: Carbon monoxide (COHb) cellular hypoxia & cyanide (HCN) inhibition│
- │ of mitochondrial cytochrome c oxidase ──► Immediate loss of consciousness. │
- │ [2] BURN ENCEPHALOPATHY: Cytokine-mediated disruption of the blood-brain barrier │
- │ (TNF-α, IL-1β, IL-6), cerebral edema, microglial activation, and neuroinflammation.│
- │ [3] METABOLIC / ELECTROLYTE CRISES: Rapid sodium fluctuations (cerebral edema vs │
- │ central pontine myelinolysis), severe hypophosphatemia, and uremic encephalopathy. │
- │ [4] ICU DELIRIUM: Sleep fragmentation, continuous lighting, high-dose continuous opioid│
- │ and benzodiazepine infusions, prolonged mechanical ventilation, and immobility. │
- └────────────────────────────────────────────────────────────────────────────────────────┘
- Delirium Assessment and Non-Pharmacological Bundles
Screening: Screen all burn ICU patients every shift using validated instruments: the Confusion Assessment Method for the ICU (CAM-ICU) or the Intensive Care Delirium Screening Checklist (ICDSC) .
The ABCDEF Bundle:
A (Assess/Manage Pain): Multimodal analgesia (acetaminophen, ketamine, neuropathic agents) to minimize continuous opioid infusions.
B (Both SAT and SBT): Daily spontaneous awakening trials and spontaneous breathing trials.
C (Choice of Sedation): Targeted light sedation (RASS -1 to 0); prioritize dexmedetomidine or propofol ; strictly avoid continuous benzodiazepine infusions (lorazepam, midazolam) which are independent drivers of delirium.
D (Delirium Monitoring/Management): Reorient frequently, ensure daylight exposure, minimize nighttime interventions, provide glasses/hearing aids.
E (Early Mobility): Passive/active range of motion within 24 hours of admission; out-of-bed mobilization.
F (Family Engagement): Involve family members at the bedside to anchor cognitive orientation.
Peripheral Compression Neuropathies
Severe interstitial edema, bulky circumferential dressings, and improper positioning can cause severe peripheral nerve entrapment:
Common Peroneal Nerve (Fibular Head): Compression of the lateral knee against bed rails or tight dressings causes foot drop and loss of dorsal foot sensation. Prevention: Pad the lateral fibular head and maintain feet in neutral dorsiflexion ( 90 ∘ 90^\circ 9 0 ∘ ) using custom splints.
Ulnar Nerve (Cubital Tunnel): Sustained elbow flexion ( > 90 ∘ >90^\circ > 9 0 ∘ ) or compression against the armboard compresses the ulnar nerve at the medial epicondyle, causing claw hand deformity and numbness in digits 4 and 5. Prevention: Splint elbows in extension ( 0 – 10 ∘ 0–10^\circ 0–1 0 ∘ ) or slight functional flexion ( < 30 ∘ <30^\circ < 3 0 ∘ ) with forearm supination.
Brachial Plexus: Excessive neck extension/rotation or hyperabduction of the shoulder ( > 90 ∘ >90^\circ > 9 0 ∘ ) stretches the brachial plexus, leading to widespread upper extremity paresis.
2. Hematological Alterations: Hemoconcentration to Anemia of Burn Injury
The hematologic response to severe burns undergoes an extreme biphasic transition: HEMATOLOGIC TRAJECTORY ACROSS BURN PHASES
- ┌────────────────────────────────────────┬────────────────────────────────────────┐
- │ RESUSCITATION PHASE (0–24 Hours) │ FLOW / ACUTE PHASE (Days 2 to 30+)│
- ├────────────────────────────────────────┼────────────────────────────────────────┤
- │ • ACUTE HEMOCONCENTRATION │ • ANEMIA OF BURN INJURY │
- │ • Plasma volume leaks into interstitium│ • Microangiopathic thermal hemolysis │
- │ • Hematocrit spikes to 55% – 65% │ • Shortened RBC lifespan (30–50% drop) │
- │ • Markedly elevated blood viscosity │ • Inflammatory marrow suppression │
- │ • Microvascular stasis & sludging │ • Massive surgical excision blood loss │
- │ • False normal/high hemoglobin │ • Hemoglobin drops to 5.0 – 7.0 g/dL │
- └────────────────────────────────────────┴────────────────────────────────────────┘
- Pathophysiology of Anemia of Burn Injury
Thermal Microangiopathic Hemolysis: Direct heating of erythrocytes passing through burned dermal capillary beds causes cellular denaturation, spectrin fragmentation, spherocyte formation, and osmotic fragility. Damaged RBCs undergo immediate intravascular lysis or rapid splenic clearance.
Shortened RBC Lifespan: Circulating inflammatory mediators, lipid peroxides, and altered erythrocyte membrane deformability shorten the normal 120-day RBC lifespan down to 30 to 40 days .
Suppression of Erythropoiesis: Inflammatory cytokines (TNF-α, IL-1β, IL-6, Interferon-gamma) stimulate hepatic hepcidin synthesis, trapping iron inside macrophages and ferritin stores. Concurrently, bone marrow erythroid progenitor cells become resistant to endogenous erythropoietin (EPO).
Surgical and Phlebotomy Blood Loss: Tangential excision of extensive burn eschar down to bleeding, viable tissue results in massive blood loss (often 0.5 to 1.0 mL of blood lost per cm² of burn excised ). Daily diagnostic laboratory phlebotomy in the ICU further exacerbates blood loss.
- Blood Transfusion Strategy: Restrictive vs. Liberal BLOOD TRANSFUSION STRATEGY IN BURN CRITICAL CARE
- ┌────────────────────────────────────────────────────────────────────────────────────────┐
- │ RESTRICTIVE TRANSFUSION TRIGGER │
- │ (Hemoglobin < 7.0 – 8.0 g/dL / Hematocrit < 21 – 24%) │
- ├────────────────────────────────────────────────────────────────────────────────────────┤
- │ • Standard of care in hemodynamically stable burn ICU patients. │
- │ • Avoids Transfusion-Related Immunosuppression (TRIM): decreases burn sepsis by >30%. │
- │ • Decreases Transfusion-Related Acute Lung Injury (TRALI) and circulatory overload (TACO)│
- │ • Transfusion is indicated ONLY if: │
- │ - Hemoglobin < 7.0 g/dL │
- │ - Active, uncontrolled intraoperative / wound hemorrhage │
- │ - Physiological evidence of tissue hypoxia: ScvO2 < 65%, elevated lactate, or active │
- │ myocardial ischemia (ST-segment changes in pre-existing coronary artery disease) │
- └────────────────────────────────────────────────────────────────────────────────────────┘
- 3. Burn Coagulopathy & Venous Thromboembolism (VTE) Prophylaxis
Burn trauma triggers profound disruptions in the hemostatic balance, alternating between acute microvascular hypercoagulability and consumption coagulopathy . BURN COAGULOPATHY DYNAMICS
- ┌────────────────────────────────────────────────────────────────────────────────────────┐
- │ Endothelial Thermal Injury & Denudation ──► Massive Tissue Factor (TF) Expression │
- │ │ │
- │ ▼ │
- │ Uncontrolled Thrombin Generation & Platelet Activation ──► Microvascular Thrombosis │
- │ │ │
- │ ▼ │
- │ Depletion of Natural Anticoagulants: Antithrombin III (AT-III), Protein C & Protein S │
- │ │ │
- │ ▼ │
- │ Impaired Fibrinolysis (Elevated PAI-1) ──► PERSISTENT PROTHROMBOTIC STATE │
- │ │ │
- │ ▼ │
- │ Consumptive Thrombocytopenia & Clotting Factor Exhaustion during Sepsis / Excision │
- │ │ │
- │ ▼ │
- │ ACUTE CONSUMPTION COAGULOPATHY & DIFFUSE BLEEDING │
- └────────────────────────────────────────────────────────────────────────────────────────┘
- Venous Thromboembolism (VTE) Risk and Chemical Prophylaxis
Burn patients meet all three elements of Virchow's Triad :
Endothelial Injury: Direct thermal vascular destruction and systemic cytokine inflammation.
Hypercoagulability: Depleted Antithrombin III, elevated factor VIII, and circulating microparticles.
Venous Stasis: Prolonged bedrest, limb immobilization, and extrinsic edema compression.
Without aggressive thromboprophylaxis, Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) occur in up to 25% to 30% of extensive burn patients .
Anti-Xa Guided Thromboprophylaxis Protocol:
Pharmacological Agent: Low-Molecular-Weight Heparin (LMWH - Enoxaparin) is strongly preferred over unfractionated heparin.
Burn Pharmacokinetic Challenge: Due to massive third-spacing, hyperdynamic renal clearance (GFR > 150 mL/min >150\text{ mL/min} > 150 mL/min ), and altered volume of distribution, standard fixed-dose enoxaparin (e.g., 30 mg SC q12h or 40 mg daily) frequently results in subtherapeutic anticoagulation .
Anti-Xa Monitoring: Measure peak anti-Xa levels exactly 4 hours after the third or fourth dose :
Target Prophylactic Anti-Xa Range: 0.2 to 0.4 IU/mL (or 0.3–0.5 IU/mL in high-risk centers).
Titrate enoxaparin dosage upward (often requiring 40–60 mg SC q12h) to achieve target levels.
Mechanical Compression: Intermittent pneumatic compression (IPC) devices and graduated compression stockings must be applied continuously to all unburned extremities .
4. Musculoskeletal Protection & Heterotopic Ossification (HO)
Major burn injuries place the musculoskeletal system under severe stress through hypermetabolic muscle catabolism, fibrotic contractures, and abnormal bone formation. HETEROTOPIC OSSIFICATION (HO) IN BURNS
- ┌────────────────────────────────────────────────────────────────────────────────────────┐
- │ Pathophysiology: Abnormal formation of mature, lamellar trabecular bone in periarticular│
- │ soft tissues and joint capsules (NOT within the joint space itself). │
- │ Driven by: Severe hypercalcemia/hyperphosphatemia flux, local tissue hypoxia, prolonged │
- │ immobilization, and osteogenic cytokine cascades (BMP-2, BMP-4, TGF-β). │
- ├────────────────────────────────────────────────────────────────────────────────────────┤
- │ MOST COMMON SITES: │
- │ 1. Elbow (Postero-medial aspect) — Most frequent (>60% of all burn HO cases) │
- │ 2. Hip (Anterior / Posterior capsular spaces) │
- │ 3. Shoulder (Subacromial / Glenohumeral spaces) │
- ├────────────────────────────────────────────────────────────────────────────────────────┤
- │ CLINICAL PRESENTATION: │
- │ • Sudden, unexplained loss of joint range of motion (ROM) with a hard, "bony" end-feel│
- │ • Localized periarticular warmth, erythema, swelling, and severe focal pain │
- │ • Ulnar nerve compression neuropathy (frequently associated with medial elbow HO) │
- ├────────────────────────────────────────────────────────────────────────────────────────┤
- │ DIAGNOSIS & MANAGEMENT: │
- │ • Serum Alkaline Phosphatase (ALP): Markedly elevated (early biochemical marker). │
- │ • Imaging: Plain radiographs (late finding, 3–6 weeks); 3D CT scan (definitive map). │
- │ • Conservative Nursing Management: Gentle, active/active-assisted ROM within pain-free │
- │ limits; NEVER perform forceful, aggressive passive manipulation (causes micro-tears │
- │ and accelerates bone formation). │
- │ • Definitive Treatment: Surgical excision of mature ectopic bone after wound healing. │
- └────────────────────────────────────────────────────────────────────────────────────────┘
- Anti-Deformity Positioning Principles
Anatomical Region Position of Deformity (Contracture Tendency) Anti-Deformity Position (Clinical Standard)
Neck Flexion, chin-on-chest Hyperextension ; no pillows under head; use neck extension collar or mattress wedge.
Shoulders / Axillae Adduction, internal rotation Abduction to 90° , external rotation; positioned on aeroplane splints or bedside armboards.
Elbows Flexion, pronation Full extension (0°–10°) , neutral to supinated; anterior molded splints.
Wrists Flexion Extension (20°–30°) .
Hands (Intrinsic Minus) MCP hyperextension, IP flexion (claw hand) Intrinsic Plus (Safe Position): Wrist ext 20°–30°, MCP flex 70°–90°, IP full ext (0°), thumb abducted.
Hips Flexion, adduction, external rotation Neutral extension (0°) , slight abduction (15°–20°); trochanter rolls.
Knees Flexion Full extension (0°) ; posterior knee extension splints.
Ankles / Feet Plantarflexion (equinus / foot drop) Neutral dorsiflexion (90°) ; custom multi-podus boots or molded splints with heel relief.